ArticleFrontiers in neuroscience2023
Identification and discovery of imaging genetic patterns using fusion self-expressive network in major depressive disorder.
Article in Frontiers in neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 3 citations in OpenAlex.
- Decoding visual pathway damage in pituitary macroadenomas: insights from retinal nerve fiber layer and visual field analysis.International ophthalmology · 2026Article
- SIRT1 as a potential target for age-related eye diseases: mechanisms and therapeutic strategies.Human cell · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Major depressive disorder (MDD) is a prevalent mental illness, with severe symptoms that can significantly impair daily routines, social interactions, and professional pursuits. Recently, imaging genetics has received considerable attention for understanding the pathogenesis of human brain disorders. However, identifying and discovering the imaging genetic patterns between genetic variations, such as single nucleotide polymorphisms (SNPs), and brain imaging data still present an arduous challenge. Most of the existing MDD research focuses on single-modality brain imaging data and neglects the complex structure of brain imaging data. Methods: In this study, we present a novel association analysis model based on a self-expressive network to identify and discover imaging genetics patterns between SNPs and multi-modality imaging data. Specifically, we first build the multi-modality phenotype network, which comprises voxel node features and connectivity edge features from structural magnetic resonance imaging (sMRI) and resting-state functional magnetic resonance imaging (rs-fMRI), respectively. Then, we apply intra-class similarity information to construct self-expressive networks of multi-modality phenotype features via sparse representation. Subsequently, we design a fusion method guided by diagnosis information, which iteratively fuses the self-expressive networks of multi-modality phenotype features into a single new network. Finally, we propose an association analysis between MDD risk SNPs and the multi-modality phenotype network based on a fusion self-expressive network. Results: Experimental results show that our method not only enhances the association between MDD risk SNP rs1799913 and the multi-modality phenotype network but also identifies some consistent and stable regions of interest (ROIs) multi-modality biological markers to guide the interpretation of MDD pathogenesis. Moreover, 15 new potential risk SNPs highly associated with MDD are discovered, which can further help interpret the MDD genetic mechanism. Discussion: In this study, we discussed the discriminant and convergence performance of the fusion self-expressive network, parameters, and atlas selection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.